AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 279 filers reported holding AVANOS MED INC in Q4 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $784,536 | +231.1% | 38,800 | +318.6% | 0.03% | +222.2% |
| Q2 2023 | $236,941 | -19.6% | 9,270 | -6.5% | 0.01% | -25.0% |
| Q1 2023 | $294,813 | -27.2% | 9,913 | -33.8% | 0.01% | -50.0% |
| Q4 2022 | $405,115 | -53.4% | 14,971 | -62.5% | 0.02% | -55.6% |
| Q3 2022 | $870,000 | -33.7% | 39,960 | +2.1% | 0.05% | +5.9% |
| Q1 2022 | $1,312,000 | +6.7% | 39,153 | +10.4% | 0.05% | -7.3% |
| Q4 2021 | $1,230,000 | -35.6% | 35,472 | -42.0% | 0.06% | -49.5% |
| Q3 2021 | $1,910,000 | +618.0% | 61,210 | +955.3% | 0.11% | +808.3% |
| Q4 2020 | $266,000 | -19.4% | 5,800 | -41.6% | 0.01% | -20.0% |
| Q3 2020 | $330,000 | -56.8% | 9,939 | -65.0% | 0.02% | -72.7% |
| Q1 2020 | $764,000 | -66.4% | 28,360 | -57.9% | 0.06% | -45.0% |
| Q4 2019 | $2,273,000 | +967.1% | 67,437 | +1087.7% | 0.10% | +809.1% |
| Q3 2019 | $213,000 | -92.2% | 5,678 | -91.1% | 0.01% | -93.3% |
| Q1 2019 | $2,720,000 | +83.8% | 63,735 | +92.9% | 0.16% | +39.8% |
| Q4 2018 | $1,480,000 | – | 33,032 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,482,743 | $113,908,000 | 6.40% |
| RGM Capital, LLC | 1,984,455 | $91,047,000 | 3.97% |
| Cove Street Capital, LLC | 204,438 | $9,380,000 | 1.66% |
| Millrace Asset Group, Inc. | 41,200 | $1,890,000 | 1.32% |
| Phocas Financial Corp. | 142,037 | $6,516,000 | 1.00% |
| Champlain Investment Partners, LLC | 3,470,935 | $159,246,000 | 0.91% |
| HEARTLAND ADVISORS INC | 231,533 | $10,623,000 | 0.76% |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | 481,042 | $22,070,000 | 0.33% |
| Wakefield Asset Management LLLP | 14,653 | $672,000 | 0.28% |
| S.A. Mason LLC | 6,527 | $299,000 | 0.25% |